Enliven Therapeutics shares keep Outperform score from Mizuho with optimistic trial knowledge By Investing.com
Enliven Therapeutics (NASDAQ: ELVN) has acquired a reaffirmation of its Outperform score…
By
admin
Enliven Therapeutics (NASDAQ: ELVN) has acquired a reaffirmation of its Outperform score…
Sign in to your account